Worth reading
55In focus
Scored from 2 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
448500
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Monthly report on the exercise status of stock acquisition rights with an exercise price adjustment clause
発行・処分する株式数
Number of shares delivered during the relevant month: 448,500 shares (448,500 new shares and 0 treasury shares transferred)
発行済株式総数
Exercise ratio during the relevant month: 6.02% (relative to the total number issued); exercise ratio subject to exercise restrictions: 1.49%
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
Exercise prices during the relevant month: ¥266.4, ¥229.9, ¥228.2, ¥225.5 and ¥226.8. Details of the adjustment provisions and floor: Not disclosed
Number of Stock Acquisition Rights
Number issued: Since 4,485 rights represent 6.02% of the total number issued, the total number issued is implied to be approximately 74,500, although this is not stated in the document. Number of rights remaining unexercised as of the end of the month preceding the relevant month: 69,634; number remaining unexercised as of the end of the relevant month: 65,149
Procedures under the Corporate Code of Conduct
Describes compliance with exercise restrictions under Article 434 of the Tokyo Stock Exchange's Securities Listing Regulations and the Japan Securities Dealers Association's Rules Concerning the Handling of Third-Party Allotments and Other Matters
Most recent equity financing
Issued on 30 March 2026: 7th Series of Stock Acquisition Rights (with Provisions for Adjustment of Exercise Price); amount: Not disclosed
| Item | Details |
|---|---|
| Type of issuance or disposal | Monthly report on the exercise status of stock acquisition rights with an exercise price adjustment clause |
| Number of shares to be issued or disposed of | Number of shares delivered during the relevant month: 448,500 shares (448,500 new shares and 0 treasury shares transferred) |
| Dilution Rate | Exercise ratio during the relevant month: 6.02% (relative to the total number issued); exercise ratio subject to exercise restrictions: 1.49% |
| Total number of issued shares | 30,759,200 shares (as of the end of the month preceding the relevant month) → Not disclosed |
| Exercise price | Exercise prices during the relevant month: ¥266.4, ¥229.9, ¥228.2, ¥225.5 and ¥226.8. Details of the adjustment provisions and floor: Not disclosed |
| Number of Stock Acquisition Rights | Number issued: Since 4,485 rights represent 6.02% of the total number issued, the total number issued is implied to be approximately 74,500, although this is not stated in the document. Number of rights remaining unexercised as of the end of the month preceding the relevant month: 69,634; number remaining unexercised as of the end of the relevant month: 65,149 |
| Procedures under the Corporate Code of Conduct | Describes compliance with exercise restrictions under Article 434 of the Tokyo Stock Exchange's Securities Listing Regulations and the Japan Securities Dealers Association's Rules Concerning the Handling of Third-Party Allotments and Other Matters |
| Most recent equity financing | Issued on 30 March 2026: 7th Series of Stock Acquisition Rights (with Provisions for Adjustment of Exercise Price); amount: Not disclosed |
Items this document does not state (20)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allotteeIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report the monthly exercise status of the 7th Series of Stock Acquisition Rights (with Provisions for Adjustment of Exercise Price) in May 2026.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.